Accounting for approximately 12% of the entire fungal infection treatments space, onychomycosis treatment has been witnessing a high prevalence-low awareness scenario over the years. However, gradually increasing awareness about the potential threats of onychomycosis and growing availability of treatments for the condition clearly point to a promising outlook for onychomycosis treatment market over the course of coming years.

The roughly US$ 4.5 billion global market for onychomycosis treatment is slated to observe robust year on year revenue growth of 6.4% in 2019. A new market research study by Future Market Insights throws light on the increasing role of combination therapy recommendations in supporting demand growth of onychomycosis treatment, in the near future.

Drugs Remain a Favored Choice of Treatment for Onychomycosis

While the line of treatment for onychomycosis is diverse, drugs remain the first line of onychomycosis treatment – with over 80% market value share – owing to consistently high success rate, says the report.

High treatment penetration of topical products is a major highlight of the global onychomycosis treatment market report.

Drugs, alone represent between 40-50% success rate, whereas rise up to an even higher success rate – in combination with photodynamic therapy.

The lower price point compared to high-end photodynamic or laser therapy is projected to boost patient preference for drugs in onychomycosis treatment.

Source: Click here